Hexane

Hexane

SCHEMBL4203459

CC(C)CO.CCCCCC.CCCCCC.CCCCCC.CCCCCC.CCCCCC.CCCCCC.CCCCCC.CCCCCC.CCCCCC

nearest known ligand 0.64

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.64
SMN1; SMN2 Q16637 1/20 0.53
LMNA P02545 5/20 0.52
ALDH1A1 P00352 3/20 0.50
HSD17B10 Q99714 1/20 0.50
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
THRB P10828 1/20 0.47
OPRM1 P35372 1/20 0.43
CYP2D6 P10635 2/20 0.42
SPHK1 Q9NYA1 1/20 0.42
GMNN O75496 1/20 0.42
POLB P06746 1/20 0.42
THPO P40225 1/20 0.42
MTOR P42345 1/20 0.42
BLM P54132 1/20 0.42
KDM4E B2RXH2 1/20 0.42
TP53 P04637 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hexane SCHEMBL8099313 1.00 TSHR (0.64) TSHRSMN1; SMN2LMNAALDH1A1HSD17B10
Heptane SCHEMBL11043045 0.97 TSHR (0.60) TSHRSMN1; SMN2LMNAALDH1A1HSD17B10
Decane SCHEMBL5449023 0.97 TSHR (0.60) TSHRSMN1; SMN2LMNAALDH1A1HSD17B10
Octane SCHEMBL27973378 0.97 TSHR (0.60) TSHRSMN1; SMN2LMNAALDH1A1HSD17B10
Heptane SCHEMBL23751339 0.94 TSHR (0.56) TSHRSMN1; SMN2LMNAALDH1A1HSD17B10
Isobutanol SCHEMBL27914538 0.93 TSHR (0.64) TSHRSMN1; SMN2LMNAALDH1A1HSD17B10
1-Pentanol SCHEMBL2917883 0.91 SMN1; SMN2 (0.71) TSHRSMN1; SMN2LMNAALDH1A1HSD17B10
Octanol SCHEMBL18986690 0.88 LMNA (0.72) TSHRSMN1; SMN2LMNAALDH1A1HSD17B10
1-Hexanol SCHEMBL8415693 0.88 LMNA (0.72) TSHRSMN1; SMN2LMNAALDH1A1HSD17B10
Isobutanol SCHEMBL1128320 0.87 ALDH1A1 (0.69) TSHRSMN1; SMN2LMNAALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8222458-B2 Process or synthesis of (3S)- and (3R)-3-hydroxy-beta-ionone, and their transformation to zeaxanthin and beta-cryptoxanthin UNIVERSITY OF MARYLAND, COLLEGE PARK (US) 2012-07-17 US disclosed
US-20090311761-A1 Process for Synthesis of (3S)- and (3R)-3-Hydroxy-Beta-Ionone, and Their Transformation to Zeaxanthin and Beta-Cryptoxanthin UNIVERSITY OF MARYLAND, COLLEGE PARK 2009-12-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090311761-A1 Process for Synthesis of (3S)- and (3R)-3-Hydroxy-Beta-Ionone, and Their Transformation to Zeaxanthin and Beta-Cryptoxanthin GRK1, HSD3B1, ALDH1A2 TSHR 2720/4885SMN1; SMN2 3091/4885LMNA 118/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.